ELIEM THERAPEUTICS INC (ELYM) Forecast, Price Target & Analyst Ratings

NASDAQ:ELYM • US28658R1068

Current stock price

5.11 USD
-0.05 (-0.97%)
At close:
5.1 USD
-0.01 (-0.2%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ELIEM THERAPEUTICS INC (ELYM).

Forecast Snapshot

Consensus Price Target

Price Target
$4.59
-10.18% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$4.59
Upside
-10.18%
From current price of $5.11 to mean target of $4.59, Based on 6 analyst forecasts
Low
$4.04
Median
$4.59
High
$5.25

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for ELYM. The average price target is 4.59 USD. This implies a price decrease of -10.18% is expected in the next year compared to the current price of 5.11.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ELYM Current Analyst RatingELYM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

ELYM Historical Analyst RatingsELYM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
ELYM was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ELYM.
In the previous month the buy percentage consensus was at a similar level.
ELYM was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-03-08HC Wainwright & Co.Reiterate Neutral
2023-02-10HC Wainwright & Co.Downgrade Buy -> Neutral
2022-10-28HC Wainwright & Co.Initiate Buy
2022-08-16SVB LeerinkMaintains Outperform
2022-07-11SVB LeerinkMaintains Outperform
2022-04-26GuggenheimDowngrade Buy -> Neutral
2022-04-26SVB LeerinkMaintains Outperform
2021-09-07GuggenheimInitiate Buy
2021-09-07SVB LeerinkInitiate Outperform
2021-09-07StifelInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2024 - 2025

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
ELYM revenue by date.ELYM revenue by date.
N/AN/A
EBITDA
YoY % growth
ELYM ebitda by date.ELYM ebitda by date.
N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ELYM ebit by date.ELYM ebit by date.
-7.45M-20.93M
-180.94%		-35.67M
-70.43%		-45.14M
-26.55%		-21.466M
52.45%		N/A
-65.15%		N/A
-49.29%
Operating Margin
ELYM operating margin by date.ELYM operating margin by date.
N/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ELYM eps by date.ELYM eps by date.
N/AN/AN/A-1.72
73.28%		N/A
22.91%		N/A
60.00%		N/A
-19.23%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ELYM Yearly EPS VS EstimatesELYM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -2 -4 -6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ELIEM THERAPEUTICS INC / ELYM Forecast FAQ

What is the average price target for ELIEM THERAPEUTICS INC (ELYM) stock?

6 analysts have analysed ELYM and the average price target is 4.59 USD. This implies a price decrease of -10.18% is expected in the next year compared to the current price of 5.11.

How do analysts rate ELIEM THERAPEUTICS INC (ELYM)?

The consensus rating for ELIEM THERAPEUTICS INC (ELYM) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.